Jushi Holdings Inc. JUSH

FY2025 · ended Dec 31, 2025 · Revenue $262.91M, +2.1% YoY · Filed Mar 31, 2026

Jushi Holdings Inc. (JUSH) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $262.9 million and a net loss of $68.6 million. Free cash flow was $1.6 million. As of Sep 30, 2026 it held $28.7 million in cash and investments and $297.2 million in total debt.

Revenue (TTM)
$276.54M
+6.2% vs year-ago TTM
Net income (TTM)
$-55.25M
+15.7% vs year-ago TTM
Operating cash flow (TTM)
$18.99M
+0.9% vs year-ago TTM
Free cash flow (TTM)
$6.08M
+66.5% vs year-ago TTM
EPS (TTM)
$-0.28
+16.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
199.70M
+0.0% vs prior year
Net cash
$-268.45M
as of Sep 30, 2026
Operating margin
2.4%
FY 2026

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
JUSH (OTC)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Boca Raton, FL
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1909747

Other Medicinal Chemicals & Botanical Products companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
Revenue
$262.9M
$257.5M
$269.4M
$284.3M
Operating income
$4.9M
$10.9M
-$2.8M
-$220.3M
Net income
-$68.6M
-$48.8M
-$65.1M
-$202.3M
Diluted EPS
-$0.35
-$0.25
-$0.33
-$1.44
Operating cash flow
$17.7M
$21.6M
-$3.3M
-$21.4M
Free cash flow
$1.6M
$16.9M
-$14.1M
-$78.3M
Total assets
$422.3M
$440.3M
$463.4M
$529.3M
Total liabilities
$537.7M
$490.6M
$471.0M
$483.4M
Stockholders' equity
-$115.3M
-$50.2M
-$6.2M
$47.3M
Cash and investments
$24.0M
$19.5M
$26.0M
$26.2M
Total debt
$293.4M
$271.1M
$298.8M
$321.2M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 28, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 28, 2026 Oct 28, 2026
10-Q Quarterly report Jul 28, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 28, 2026 Jul 28, 2026
8-K Current report
Shareholder vote results, Other events
Jun 24, 2026 Jun 24, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.